Microdose Therapeutx, Inc.

Andrew Technologies, LLC

Cytosorbents Corporation

Cytosorbent, Inc.

Philip Chan

Anand V Gumaste

Thomas D Golobish

Robert L Albright

Vincent J Capponi

Wei-Tai Young

Mark S Andrew

Christopher P Godek

Douglas E Weitzel

Scott Fleming

The invention provides an inhalation device using an electrically driven vibratory element for releasing a drug dose into a flow channel, and a controller for activating/deactivating the vibratory element. A sensor arrangement is able to differentiate between inhalation flow and exhalation flow through the flow channel, to assist in forming a model of the breathing pattern of the user. The device can detect reliably inhalation flow patterns from patients of all ages.

Inhalation device, control method and computer program

A size-selective hemocompatible porous polymeric adsorbent system is provided, the polymer system comprises at least one crosslinking agent and at least one dispersing agent, and the polymer has a plurality of pores with diameters in the range from about 17 to about 40,000 Angstroms.

Size-selective hemocompatible polymer system

A laboratory animal pharmaceutical testing device comprising a substantially closed animal holding cell, having a dry powder generator communicating through a wall of the cell, and one or more filtered inlets for permitting exchange of fresh air into the cell.

Laboratory animal pulmonary dosing device

Target tissue may be removed from a subject using a cannula that has an interior cavity and an orifice configured to permit material to enter the cavity. This is accomplished by generating a negative pressure in the cavity so that a portion of the tissue is drawn into the orifice. Fluid is then delivered, via a conduit, so that the fluid exits the conduit within the cavity and impinges against the portion of the tissue that was drawn into the orifice. The fluid is delivered at a pressure and temperature that causes the tissue to soften, liquefy, or gellify. The tissue that has been softened, liquefied, or gellified is then suctioned away.

Liposuction based on tissue liquefaction

A size-selective hemocompatible porous polymeric adsorbent system is provided, the polymer system comprises at least one polymer with a plurality of pores, and the polymer has at least one transport pore with a diameter from about 250 Angstroms to about 2000 Angstroms, and the polymer has a transport pore volume greater than about 1.8% to about 78% of a capacity pore of volume of the polymer.

Growing community of inventors

Cherry Hill, NJ, United States of America

Philip Chan